Nucleate Bio is a nonprofit, non-dilutive entrepreneurship program for aspiring biotech startup founders. The program is advised by George Church and Robert Langer, among 100+ world-class innovators/startup founders and investors hailing from Lux Capital, Flagship Pioneering, Polaris Partners, Alexandria, Pfizer Ventures, Bayer, and many more.
Nucleate Bio is launching in Fall 2021 in New York. Participating teams will be early-career scientists and business-minded graduate students with an ambitious biology-driven vision. Teams will meet potential co-founders, receive one-on-one mentorship, and gain opportunities for non-dilutive funding and perks valued at $200,000. See attached for additional information and brief answers to frequently asked questions.
The info session on Tuesday, May 4th at 6 PM ET is an opportunity to meet the Nucleate Bio team, learn more about the program, and prepare for the application process.